原发性肺腺癌诊断与治疗的探讨

我院１９８３年３月～１９９１年１２月对１１５例原发性肺腺癌患者进行了外科治疗，占同期肺癌手术例的２７．３％。其１、３、５年生存率分别为６７．０％、３５．４％、２１．８％，全组无手术死亡。作者分析讨论了其独特的临床特点与影响预后的因素。认为肺腺癌的发病率正在逐年增长，为了提高远期疗效，应重视早期确诊、尽早手术、Ｎ２淋巴结的彻底清除以及术后配合综合治疗。

Diagnosis and Treatment of Primary Pulmonary Adenocarcinoma

From Mar.1983 to Dec.1991,115 patients of primary pulmonary adenocarcinoma were surgically treated in our unit.This series comprised 27.3% of the total number of lung cancer patients operated on during the same period of time.The 1,3,5-year survival rates showed 67.0%,35.4%,and 21.8% respectively. There was no operative mortality.The authors discussed it's own clinical characteristics and the factors influencing the effectiveness and believe that the Incidence rate for adenocarcinoma of the lung is increasing year after year.To improve the survival rate of pulmonary adenocarcinoma,it is important to make early diagnosis,to perform radical resection including N2 lymph nodes and to adopt comprehensive adjuvant therapy after operation.